Chemical Compound

Epirubicin hydrochloride

CAS Registry Number 56390-09-1

Back to search Request a Quote

Primary Record

Epirubicin hydrochloride

In stock: 8,969 g
Purity: 99.4 %
CAS: 56390-09-1

Compound Identifiers & Properties

CAS: 56390-09-1
PubChem CID: 65348
SMILES: C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl
Canonical SMILES: COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1.Cl

Names & Synonyms

Epirubicin hydrochloride
Epirubicin HCl
Ellence
Pharmorubicin
Farmorubicin
Farmorubicina
56390-09-1
Epirubitec
doxorubicin
Epirubicin Ebewe
Epidoxorubicin
Adriamycin
Pidorubicin
Pharmorubicin Pfs
4'-epi-Adriamycin
Ellence (TN)
epi-Doxorubicin HCl
4'-epi-Doxorubicin
Epidoxorubicin hydrochloride
IMI-28
epirubicin (hydrochloride)
Epirubiein Hydrochloride
E-ADM
RefChem:55118
Doxorubicin Hydrochloride
4'-epi-DX
Hydrochloride, Epirubicin
4'-Epidoxorubicin hydrochloride
CCRIS 4477
4'-epi-Adriamycin hydrochloride
C27H30ClNO11
MFCD00941448
Epirubicin Hydrochloride RS
MLS001401404
SCHEMBL3165
Epirubicin hydrochloride CRS
IMI28
UNII-22966TX7J5
MLS000759412
4-Epidoxorubicin hydrochloride
C27H29NO11.ClH
NSC-759195
DTXSID50860297
EINECS 260-145-2
EPIRUBICIN HCL [VANDF]
MWWSFMDVAYGXBV-FGBSZODSSA-N
WP-697
AC1L233G
orb1310913
22966TX7J5
CHEMBL1200981
NSC 256942
SCHEMBL29379962
SCHEMBL30077487
ERK5-2O04
CHEBI:232543
Epirubicin hydrochloride [USAN:JAN]
C27H29NO11
DTXCID001475450
HY-13624AR
Pharmakon1600-01505708
AMY10308
CID65348
EX-A2654
C27-H29-N-O11.Cl-H
BBF-04657
EBC-17157
EPIRUBICIN HYDROCHLORIDE [MI]
HY-13624A
NSC759195
s1223
CPD000466308
Epirubicin HCl (4'-epidoxorubicin)?
Epirubicin hydrochloride (JP18/USP)
EPIRUBICIN HYDROCHLORIDE [JAN]
Epirubicin hydrochloride [USAN:USP:JAN]
SMR000466308
AKOS030526162
Epirubicin (hydrochloride) (Standard)
ACN-036868
BCP9000651
CCG-100950
CS-1773
EPIRUBICIN HYDROCHLORIDE [USAN]
FE22741
NC00200
56390-09-1 (HCl)
EPIRUBICIN HYDROCHLORIDE [MART.]
EPIRUBICIN HYDROCHLORIDE [USP-RS]
EPIRUBICIN HYDROCHLORIDE [WHO-DD]
AS-75323
BC208841
LS-93989
SAM001246559
SY076232
(8S-cis)-4'-Epidoxorubicin Hydrochloride
Epirubicin hydrochloride, >=90% (HPLC)
E0840
NS00087126
EPIRUBICIN HYDROCHLORIDE [ORANGE BOOK]
A10345
D02214
D83113
EPIRUBICIN HYDROCHLORIDE [EP MONOGRAPH]
EPIRUBICIN HYDROCHLORIDE [USP MONOGRAPH]
33811-EP2275420A1
33811-EP2295055A2
33811-EP2295416A2
33811-EP2298748A2
33811-EP2298764A1
33811-EP2298765A1
33811-EP2305642A2
33811-EP2311453A1
Epirubicin hydrochloride, 98% - 100MG 100mg
A857961
F811935
SR-01000763557
(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride
SR-01000763557-3
Q27253634
(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside hydrochloride
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-
(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
25316-40-9
5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-arabinohexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
Epirubicin hydrochloride, British Pharmacopoeia (BP) Reference Standard
Epirubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard
5,12-naphthacenedione,10-((3-amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosy
Epirubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard
(1S,3S)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside--hydrogen chloride (1/1)
(1S,3S)-3-GLYCOLOYL-1,2,3,4,6,11-HEXAHYDRO-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1-NAPHTHACENYL 3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSIDE HYDROCHLORIDE
(2S,4S)-4-(3-Amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyloxy)-2,5,12-trihydroxy-2-hydroxyacetyl-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride
(7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride
(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-a-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-meth oxy-5,12-naphthacenedione hydrochloride
(8S,10S)-10-{[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione hydrochloride
(8S-cis)-10-((3-Amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Hydrochloride
(8S-cis)-10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside Hydrochloride
4'-Epidoxorubicin hydrochloride; 4'-epi-Adriamycin hydrochloride; Ellence; Epidoxorubicin hydrochloride; Epirubicin hydrochloride; Farmorubicin; Pharmorubicin; (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-l-arabino-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)- (9CI); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,?12-?Naphthacenedione, 10-?[(3-?amino-?2,?3,?6-?trideoxy-?|A-?L-?arabino-?hexopyranosyl)?oxy]?-?7,?8,?9,?10-?tetrahydro-?6,?8,?11-?trihydroxy-?8-?(2-?hydroxyacetyl)?-?1-?methoxy-?, hydrochloride (1:1)?, (8S,?10S)?-
5,12-Naftacenediona, 10-[(3-amino-2,3,6-trideoxi alfa-L-arabino-hexopiranosil)] oxi-7,8,9,10-tetrahidro-6, 8,11-trihidroxi-8-(2-hidroxiacetil)-1-metoxi-,clorhidrato (1:1), (8S, 10S)-
5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-ARABINO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, HYDROCHLORIDE, (8S-CIS)-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-|_-L-arabino-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, hydrochloride (1:1), (8S,10S)-
56420-45-2
EPI